IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Svennilson Peter

Q1 2020 Holdings

Filed 2020-05-07 | 10 holdings | $49.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcus Biosciences Inc(RCUS)COM03969F109$49.1M3,540,85098.5%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$213.6K17,323,1440.4%
Constellation Pharmceticls I(CNST)COM210373106$190.2K6,051,3760.4%
Revolution Medicines Inc(RVMD)COM76155X100$174.8K7,977,3840.4%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$144.2K6,777,1510.3%
Gritstone Oncology Inc(2JQ)COM39868T105$18.1K3,102,9340.0%